• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Anesthesia

Rivanna Medical pulls down $3m

August 25, 2016 By Brad Perriello

Rivanna Medical, which makes an epidural needle guidance device, raised $3 million in an equity offering, according to a regulatory filing. Charlottesville, Va.-based Rivanna won 510(k) clearance from the FDA for its Accuro handheld needle guidance device indicated for spinal anesthesia in March 2015 and launched the device last November. A quintet of unnamed investors participated in […]

Filed Under: Funding Roundup, Imaging Tagged With: Anesthesia, Rivanna Medical

Johnson & Johnson bails on Sedasys anesthesia device

March 15, 2016 By Brad Perriello

Johnson & Johnson (NYSE:JNJ) reportedly confirmed last week that it’s discontinuing its Sedasys computerized anesthesia system, 3 years after a hard-won pre-market approval from the FDA. The federal safety watchdog denied approval for Sedasys back in 2008, prompting J&J to take another run at a PMA, which was also denied. After a rare appeal of that denial in […]

Filed Under: Endoscopic, Imaging Tagged With: Anesthesia, Ethicon, Johnson and Johnson

Medtronic buys Aircraft Medical for $110m

November 18, 2015 By Brad Perriello

Medtronic (NYSE:MDT) said today that it paid $110 million in cash to acquire video laryngoscope maker Aircraft Medical. Edinburgh-based Aircraft’s handheld McGrath laryngoscopes are designed to facilitate intubation by anesthesiologists and critical care providers, Medtronic said. “Aircraft Medical’s offerings complement our portfolio, helping us further our commitment to reducing incidents and potential complications from respiratory compromise globally. […]

Filed Under: Endoscopic, Mergers & Acquisitions Tagged With: Aircraft Medical, Anesthesia, Medtronic

Teleflex issues Class I recall of pediatric anesthesia devices

October 9, 2014 By Alexander Soule

Teleflex issues Class I recall of pediatric anesthesia devices

Filed Under: Food & Drug Administration (FDA), News Well, Pediatrics, Recalls, Respiratory Tagged With: Anesthesia, Teleflex

Another recall for Spacelabs Healthcare’s Arkon anesthesia system

April 18, 2014 By Brad Perriello Leave a Comment

Another recall for Spacelabs Healthcare's Arkon anesthesia system

The FDA slapped Spacelabs Healthcare with a Class I recall after the medical device company pulled 16 of is Arkon anesthesia delivery devices due to a software bug.

The recall, of the Arkon device equipped with version 2.0 software, involves devices sold to hospitals in North Carolina and South Carolina, according to the FDA. The Class I recall status denotes a problem that could cause serious injury or death.

Filed Under: Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance Tagged With: Anesthesia, Spacelabs Healthcare

FDA puts highest-risk label on McKesson’s anesthesia system recall

March 18, 2014 By Arezu Sarvestani Leave a Comment

Updated March 20, 2014, at 3:15 p.m. with comments from McKesson

Filed Under: Food & Drug Administration (FDA), Hospital Care, News Well, Recalls Tagged With: Anesthesia, McKesson Corp.

GE Healthcare recall gets FDA’s highest-risk label

January 7, 2014 By Arezu Sarvestani Leave a Comment

GE Healthcare recall gets FDA's highest-risk label

Filed Under: Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance, Respiratory Tagged With: Anesthesia, CareFusion Corp., GE Healthcare, Vital Signs Devices Inc.

FDA issues warning on Vital Signs’ anesthesia devices

January 3, 2014 By Chris Walker Leave a Comment

FDA issues warning on Vital Signs anesthesia device

Vital Signs Devices, a GE (NYSE:GE) Healthcare company, issued a warning for its disposable Multi Absorber Original anesthesia system after receiving complaints to a potential safety issue.

Filed Under: News Well, Recalls Tagged With: Anesthesia, GE Healthcare, Vital Signs Devices Inc.

FDA puts highest-risk label on GE Healthcare recall

October 22, 2013 By Arezu Sarvestani Leave a Comment

FDA puts highest-risk label on GE Healthcare's ventilator, anesthesia systems recall

Filed Under: Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance, Respiratory Tagged With: Anesthesia, GE Healthcare

GE Healthcare warns on software issues in anesthesia systems

October 17, 2013 By Arezu Sarvestani Leave a Comment

GE Healthcare warns on software issues in anesthesia delivery systems

GE Healthcare (NYSE:GE) issued a field correction on certain of its Avance, Avance CS2 and Aisys anesthesia delivery systems, warning that they need a software update to avoid a potential safety issue.

Filed Under: News Well, Recalls, Software / IT Tagged With: Anesthesia, GE Healthcare

Respiratory Motion aims to cut down on anesthesia-related hospital deaths

July 10, 2013 By Sony Salzman

Respiratory Motion aims to cut down on anesthesia-related hospital deaths

According to Respiratory Motion CEO Dr. Jenny Freeman, breathing problems following surgery are highly under-reported, resulting more than 50,000 deaths per year. With a new FDA clearance in hand, Freeman said the company has several "irons in the fire" for its breath-monitoring device.

Filed Under: News Well, Patient Monitoring, Respiratory, Surgical Tagged With: Anesthesia, Respiratory Motion

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy